Datasets:

Suchinthana
/

support2-1

Dataset card Viewer Files Files and versions Community

Split (1)

train · 9.11k rows

ID int64 1 9.11k	age float64 18 102	death int64 0 1	sex stringclasses 2 values	hospdead int64 0 1	slos int64 3 343	d.time int64 3 2.03k	dzgroup stringclasses 8 values	dzclass stringclasses 4 values	num.co int64 0 9	edu float64 0 31 ⌀	income stringclasses 4 values	scoma float64 0 100 ⌀	charges float64 1.17k 1.44M ⌀	totcst float64 0 633k ⌀	totmcst float64 -102.72 711k ⌀	avtisst float64 1 83 ⌀	race stringclasses 5 values	sps float64 0.2 99.2 ⌀	aps float64 0 143 ⌀	surv2m float64 0 0.97 ⌀	surv6m float64 0 0.95 ⌀	hday int64 1 148	diabetes int64 0 1	dementia int64 0 1	ca stringclasses 3 values	prg2m float64 0 1 ⌀	prg6m float64 0 1 ⌀	dnr stringclasses 3 values	dnrday float64 -88 285 ⌀	meanbp float64 0 195 ⌀	wblc float64 0 200 ⌀	hrt float64 0 300 ⌀	resp float64 0 90 ⌀	temp float64 31.7 41.7 ⌀	pafi float64 12 890 ⌀	alb float64 0.4 29 ⌀	bili float64 0.1 63 ⌀	crea float64 0.1 21.5 ⌀	sod float64 110 181 ⌀	ph float64 6.83 7.77 ⌀	glucose float64 0 1.09k ⌀	bun float64 1 300 ⌀	urine float64 0 9k ⌀	adlp float64 0 7 ⌀	adls float64 0 7 ⌀	sfdm2 stringclasses 5 values	adlsc float64 0 7.07
8,601	66.935	1	male	0	8	106	Cirrhosis	COPD/CHF/Cirrhosis	5	9	$11-$25k	0	4,510	3,092.8125	3,460.1582	7	white	23.097656	26	0.622925	0.437988	1	0	0	yes	0.75	0.5	dnr after sadm	1	53	19	110	25	36.59375	160	2	3.399902	2.599609	132	7.339844	195	54	3,200	0	1	null	1
8,602	70.02594	0	male	0	11	930	ARF/MOSF w/Sepsis	ARF/MOSF	2	10	null	0	25,514	16,332.7109	17,291.6562	21.5	white	25.796875	30	0.702881	0.612915	8	1	0	no	null	null	no dnr	11	67	7.5	122	24	35.69531	null	3.899902	0.5	1	136	null	124	13	1,800	null	0	no(M2 and SIP pres)	0
8,603	62.35699	0	female	0	4	929	COPD	COPD/CHF/Cirrhosis	4	12	$11-$25k	0	4,064	2,609.4922	4,002.37891	18	white	23.597656	26	0.796997	0.672974	1	0	0	yes	0.8	0.7	no dnr	4	67	null	101	40	35.59375	null	null	null	1.299805	134	null	90	27	null	1	2	null	2
8,604	83.948	1	male	0	4	454	Coma	Coma	3	8	null	41	4,574	3,325.3496	3,421.06836	16	white	17.898438	23	0.494995	0.422974	1	0	1	no	0.9	0.9	dnr before sadm	-1	63	14.898438	144	28	39.29688	77.64062	2	9.398438	0.799927	133	7.349609	143	10	2,375	null	4	null	4
8,605	69.10895	1	male	0	4	69	Colon Cancer	Cancer	5	12	$11-$25k	0	5,263	3,212.4961	2,303.7793	11	white	13.898438	20	0.8479	0.664917	1	1	0	metastatic	0.7	0.4	no dnr	4	143	null	118	28	36.69531	117.5	null	null	1.699951	124	7.319336	157	34	430	1	null	no(M2 and SIP pres)	1.166748
8,606	56.41599	0	male	0	46	929	ARF/MOSF w/Sepsis	ARF/MOSF	1	8	null	9	90,783	60,371.0625	61,435.9688	44.75	white	34.59375	75	0.612915	0.507935	1	0	0	no	0.2	0.2	no dnr	46	59	9.798828	102	24	36.19531	78.75	2.199707	0.199982	0.899902	133	7.419922	116	12	2,750	null	null	no(M2 and SIP pres)	2.265137
8,607	87.15698	0	male	0	22	927	COPD	COPD/CHF/Cirrhosis	2	8	under $11k	0	66,731	44,561.1875	44,812.0938	32.666657	white	31.097656	41	0.362	0.169983	9	0	0	no	0.8	0.8	no dnr	22	73	7.399414	64	20	36.39844	null	null	1.399902	1.699951	139	null	200	39	2,300	null	0	no(M2 and SIP pres)	0
8,608	76.02496	1	male	0	9	17	ARF/MOSF w/Sepsis	ARF/MOSF	1	10	null	100	98,962	66,981.1875	69,277.75	35	white	20.199219	25	0.313965	0.199982	22	1	0	no	0.6	0.5	dnr after sadm	2	148	9.298828	104	28	35.59375	240	4.699219	0.599976	1.699951	147	7.369141	106	29	1,025	null	0	<2 mo. follow-up	0
8,609	72.48199	1	female	1	42	42	COPD	COPD/CHF/Cirrhosis	3	12	null	0	72,553	49,537.2188	44,304.6562	20.25	white	23.597656	35	0.775879	0.642944	1	0	0	no	0.8	0.6	no dnr	42	77	8.599609	67	28	35.89844	null	null	null	1	139	null	115	18	1,470	5	6	<2 mo. follow-up	6
8,610	70.92096	1	female	0	7	491	MOSF w/Malig	ARF/MOSF	2	null	null	0	5,492	4,187.9258	3,486.75	8.5	white	21	45	0.747925	0.668945	1	0	0	yes	0.7	0.5	no dnr	7	67	12.699219	107	28	36.39844	null	null	null	1.199951	129	null	242	22	3,550	null	null	null	1.882568
8,611	71.26099	1	male	1	3	3	MOSF w/Malig	ARF/MOSF	1	3	$11-$25k	44	70,697	48,408.125	47,537.3438	46	white	41.5	87	0.017998	0.004	16	0	0	yes	0.5	0.5	no dnr	3	59	25.699219	70	40	36.39844	200	null	null	2.099609	130	7.399414	138	37	385	null	null	<2 mo. follow-up	2.432129
8,612	43.31799	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	2	12	null	0	21,711	14,850.7891	15,784.6484	44.5	white	34.09375	50	0.726929	0.642944	1	1	0	no	0.05	0.04	no dnr	8	94	11.798828	76	20	35.69531	400	3.699707	0.5	1.099854	138	7.399414	144	32	1,500	null	null	<2 mo. follow-up	2.335938
8,613	85.82898	1	male	1	5	5	Coma	Coma	1	6	under $11k	100	3,794	2,479.2109	2,611.87891	26	white	18.597656	23	0.159973	0.106995	1	0	1	no	0.01	0	dnr after sadm	3	111	17	81	20	36.29688	null	null	null	1.099854	133	null	155	9	5,450	null	null	<2 mo. follow-up	4.825195
8,614	72.86798	1	female	0	15	147	Lung Cancer	Cancer	1	13	$11-$25k	0	10,252	6,784.1055	7,766.06641	3	white	9.599609	10	0.814941	0.602905	1	0	0	metastatic	0.9	0.75	dnr after sadm	12	50	12.898438	104	8	39.29688	273.3125	2.5	12.298828	2.299805	146	7.539062	123	51	1,850	3	5	no(M2 and SIP pres)	5
8,615	79.53998	1	male	0	10	43	Colon Cancer	Cancer	1	8	null	0	6,102	4,132.4961	3,950.33984	9	white	20.597656	28	0.726929	0.453979	1	0	0	metastatic	0.5	0.2	dnr after sadm	1	68	7.299805	81	28	38.59375	277.5	2.5	0.799927	1	138	7.419922	168	18	1,138	0	1	<2 mo. follow-up	1
8,616	59.88498	1	female	0	8	83	COPD	COPD/CHF/Cirrhosis	2	8	under $11k	0	6,514	4,453.6914	4,030.6582	5.5	white	21	36	0.875977	0.793945	1	1	0	no	0.9	0.85	no dnr	8	66	18.597656	122	24	35.39844	233.3125	null	null	1.199951	135	7.489258	244	25	2,800	0	null	null	0.494751
8,617	52.42398	1	male	0	10	63	CHF	COPD/CHF/Cirrhosis	4	12	$25-$50k	0	8,569	5,841.957	5,122.45703	12	white	28.796875	45	0.793945	0.668945	1	1	0	no	0.75	0.5	no dnr	10	65	16.199219	70	24	39	244	3.599609	0.699951	0.899902	135	7.429688	159	12	2,775	3	2	no(M2 and SIP pres)	2
8,618	68.35297	0	female	0	7	915	CHF	COPD/CHF/Cirrhosis	4	11	under $11k	0	4,881	3,302.4414	2,992.9082	5	white	18.296875	30	0.869995	0.783936	1	0	0	no	0.8	0.6	dnr after sadm	1	139	12.798828	59	24	36.29688	260	null	0.399963	1.699951	141	7.269531	175	49	3,350	0	0	no(M2 and SIP pres)	0
8,619	75.26398	0	male	0	10	914	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	13,348	8,931.6172	8,310.21875	12	white	17.5	31	0.845947	0.792969	2	0	0	no	0.8	0.8	no dnr	10	111	14	108	26	35.69531	130.59375	3.299805	6.5	2.199707	149	7.479492	128	45	2,310	null	null	null	2.265137
8,620	81.77399	1	male	0	9	11	ARF/MOSF w/Sepsis	ARF/MOSF	0	16	null	41	68,292	44,787.375	44,734.9375	35.5	white	36.695313	69	0.136993	0.063995	10	0	0	no	0.6	0.6	dnr after sadm	6	96	9.699219	65	20	36.59375	null	3.799805	0.799927	1	134	null	311	19	null	null	null	<2 mo. follow-up	2.856445
8,621	47.23297	1	male	0	117	504	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	176,303	111,901.188	125,680	24.25	white	17.097656	24	0.893921	0.855957	8	0	0	no	0.6	0.5	dnr after sadm	86	103	5.699219	67	22	36.39844	213.03125	2.899902	3.699707	0.799927	141	7.389648	118	13	850	null	1	null	1
8,622	53.99899	0	female	0	32	909	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	null	89	65,056	44,875.375	44,177	31	white	33.796875	53	0.251953	0.14798	1	0	0	no	0.5	0.5	no dnr	32	43	19.597656	68	28	39.29688	376	null	null	1.899902	144	7.439453	176	43	2,625	null	0	no(M2 and SIP pres)	0
8,623	73.98199	0	male	0	6	909	CHF	COPD/CHF/Cirrhosis	2	8	under $11k	0	4,949	3,425.7734	2,402.29883	16	white	19.699219	23	0.837891	0.734985	1	0	0	no	null	null	no dnr	6	52	0.199982	142	26	39.09375	64	null	null	1.199951	142	7.359375	341	36	3,500	0	0	no(M2 and SIP pres)	0
8,624	73.41498	1	male	0	12	181	Lung Cancer	Cancer	4	12	null	0	8,663	5,505.293	4,598.4375	9.5	white	14.298828	8	0.73999	0.474976	1	1	0	metastatic	1	0.95	no dnr	12	122	7.799805	39	24	34.39844	null	null	null	2.699707	138	null	160	76	1,515	0	0	no(M2 and SIP pres)	0
8,625	76.63794	1	male	1	10	10	ARF/MOSF w/Sepsis	ARF/MOSF	2	8	under $11k	26	66,572	43,853.0312	42,930.1875	54.5	white	31.597656	53	0.382996	0.264954	10	0	0	no	0.7	0.65	no dnr	10	65	8	100	42	37	152.5	null	null	1.799805	140	7.419922	90	47	2,150	null	1	<2 mo. follow-up	1
8,626	60.008	1	male	0	9	392	CHF	COPD/CHF/Cirrhosis	8	14	null	0	5,204	3,598.4394	2,836.6582	7.5	white	23.097656	35	0.803955	0.68396	1	1	0	yes	0.8	0.6	no dnr	9	120	null	115	20	36.09375	null	null	null	0.699951	138	null	197	9	2,850	0	0	SIP>=30	0
8,627	68.88397	1	male	0	8	214	Lung Cancer	Cancer	1	8	$11-$25k	0	11,507	7,948.1367	6,828.77734	4	white	19.097656	12	0.653931	0.348999	1	0	0	metastatic	0.9	0.5	no dnr	8	56	6.699219	61	28	36.19531	null	3.899902	0.399963	2	136	null	98	36	null	null	1	adl>=4 (>=5 if sur)	1
8,628	75.97296	0	female	0	3	904	MOSF w/Malig	ARF/MOSF	1	12	$25-$50k	44	25,406	16,600.0938	16,141.4062	null	white	21.296875	31	0.399963	0.280945	6	0	0	metastatic	0	0	dnr after sadm	1	61	8.398438	98	34	36.79688	130.59375	null	null	4.799805	133	7.459961	106	95	3,050	null	null	adl>=4 (>=5 if sur)	2.910156
8,629	77.05096	1	male	0	5	159	Lung Cancer	Cancer	3	16	null	0	7,321	4,370.6797	4,709.70703	11	white	6.199219	8	0.850952	0.670898	1	0	0	metastatic	0.8	0.6	no dnr	5	73	12.599609	120	10	38.29688	211.09375	2.299805	1.199951	1.199951	136	7.529297	145	12	4,225	0	0	adl>=4 (>=5 if sur)	0
8,630	75.70197	1	male	0	12	109	COPD	COPD/CHF/Cirrhosis	3	15	$11-$25k	0	8,417	5,477.293	5,899.47656	10	white	14.5	26	0.873901	0.789917	1	0	0	no	0.5	0.4	dnr after sadm	5	69	5.5	71	28	36.19531	288.875	null	0.399963	1.299805	136	7.349609	175	42	1,100	3	2	adl>=4 (>=5 if sur)	2
8,631	59.409	0	male	0	31	897	ARF/MOSF w/Sepsis	ARF/MOSF	0	10	null	26	89,880	61,031.75	59,264.6562	36	white	26.597656	36	0.66394	0.566895	4	0	0	no	0.6	0.6	no dnr	31	72	8.5	122	32	36.19531	null	null	null	0.899902	138	null	159	10	null	null	0	null	0
8,632	90.38495	1	male	0	11	19	CHF	COPD/CHF/Cirrhosis	5	8	null	0	11,069	7,677.5391	7,472.29688	29.5	white	51.898438	76	0.004	0	1	0	0	metastatic	0.1	0.05	dnr after sadm	4	69	14.699219	146	26	38.09375	null	2.599609	0.399963	0.899902	134	null	125	13	950	null	null	<2 mo. follow-up	4.542969
8,633	77.29498	0	male	0	9	893	CHF	COPD/CHF/Cirrhosis	3	8	$11-$25k	0	6,750	4,606.7539	3,212.67969	17.5	white	16.398438	31	0.863892	0.775879	1	0	0	no	0.5	0.5	no dnr	9	114	10.5	73	28	35.79688	null	3.299805	0.299988	1.399902	142	7.459961	181	18	null	1	0	no(M2 and SIP pres)	0
8,634	83.91498	1	male	0	10	382	CHF	COPD/CHF/Cirrhosis	5	null	null	0	6,141	4,087.0391	3,962.13867	9	white	22.097656	38	0.764893	0.626953	1	0	1	no	null	null	no dnr	10	77	28.597656	53	22	35.69531	null	null	1.199951	1.399902	132	null	150	20	2,525	null	null	null	5.938477
8,635	81.81195	1	male	1	8	8	ARF/MOSF w/Sepsis	ARF/MOSF	1	14	under $11k	0	66,049	43,404	41,449.2812	55	white	36.695313	54	0.314941	0.201996	16	0	0	no	null	null	no dnr	8	110	4.899414	79	24	36.09375	null	null	null	1.599854	141	null	94	25	575	null	0	<2 mo. follow-up	0
8,636	73.75494	1	male	0	6	14	Colon Cancer	Cancer	2	6	under $11k	0	3,420	2,306.7441	2,380.10938	8	white	23.097656	14	0.694946	0.405945	1	0	0	metastatic	0.2	0.01	dnr after sadm	1	70	3	76	20	36.69531	null	null	0.399963	1.099854	140	null	null	null	null	null	1	<2 mo. follow-up	1
8,637	66.85596	1	female	0	3	530	COPD	COPD/CHF/Cirrhosis	2	null	null	0	1,968	1,304.7432	1,317.55957	null	white	15.798828	32	0.894897	0.824951	1	0	0	no	null	null	no dnr	3	73	9.599609	116	28	36.09375	177.125	2.599609	0.5	1.299805	131	7.359375	144	9	2,625	null	null	null	2.138184
8,638	76.68994	0	male	0	8	891	CHF	COPD/CHF/Cirrhosis	3	null	null	0	4,607	3,228.2344	2,411.64844	5.5	white	26.5	34	0.720947	0.565918	1	0	0	no	0.7	0.5	no dnr	8	107	16.597656	53	16	36.79688	null	null	null	0.799927	138	null	117	8	3,025	null	null	null	3.208008
8,639	67.07996	0	male	0	14	890	COPD	COPD/CHF/Cirrhosis	1	12	under $11k	0	13,903	7,774.2031	6,875.01953	6.666664	white	19.398438	32	0.861938	0.770996	1	0	0	no	null	null	no dnr	14	113	8.099609	107	24	36.29688	232	4.399414	0.799927	1.399902	140	7.369141	154	15	null	null	0	no(M2 and SIP pres)	0
8,640	45.125	1	male	0	11	12	MOSF w/Malig	ARF/MOSF	2	9	under $11k	0	52,438	34,762.4688	35,275.125	33.5	other	31.597656	34	0.42395	0.303955	27	0	0	yes	0.5	0.4	dnr after sadm	2	124	12.199219	162	35	38	217.125	3.199707	3.799805	4.199219	134	7.279297	163	55	3,675	null	0	<2 mo. follow-up	0
8,641	67.48499	0	female	0	4	885	CHF	COPD/CHF/Cirrhosis	4	null	null	0	2,125	1,470.4014	1,233.48926	7	white	17.398438	10	0.879883	0.800903	1	0	0	no	0.7	0.5	no dnr	4	104	12.398438	98	26	36.19531	483.3125	null	null	1.5	133	7.319336	112	19	2,555	0	null	null	0.494751
8,642	75.85797	0	female	0	21	883	ARF/MOSF w/Sepsis	ARF/MOSF	0	11	null	41	72,352	46,216.5625	51,080.4062	30.333328	white	24.097656	28	0.541992	0.426941	7	0	0	no	0.5	0.5	no dnr	21	68	17	52	10	35.89844	172	null	null	1.399902	135	7.359375	103	50	1,075	null	0	no(M2 and SIP pres)	0
8,643	28.88199	1	male	0	19	290	ARF/MOSF w/Sepsis	ARF/MOSF	2	11	under $11k	0	49,937	34,050.25	38,943.3125	30.333328	white	31.898438	51	0.776978	0.704956	6	1	0	no	0.5	0.5	no dnr	19	59	12.699219	115	26	39.29688	180	2.399902	0.299988	0.699951	145	7.479492	181	4	1,348	null	null	null	2.242676
8,644	70.18799	1	female	0	4	28	Lung Cancer	Cancer	2	13	null	0	3,494	2,189.0508	1,769.17969	9	white	14.099609	18	0.75	0.48999	1	0	0	metastatic	0.3	0.1	dnr after sadm	1	125	4.399414	56	24	36.29688	null	null	null	0.899902	141	null	167	15	750	null	null	<2 mo. follow-up	2.099609
8,645	57.21799	1	male	0	22	344	Coma	Coma	0	8	$11-$25k	100	31,051	21,368.125	19,818.8594	21	white	19	29	0.429993	0.356995	1	0	0	no	0.1	0.05	no dnr	22	123	5.5	134	26	39.09375	170	2.199707	0.599976	4.299805	139	7.319336	149	23	1,299	null	0	adl>=4 (>=5 if sur)	0
8,646	45.13599	0	male	0	8	878	Cirrhosis	COPD/CHF/Cirrhosis	3	null	null	0	8,785	5,756.7539	5,192.65625	8.5	white	23.5	47	0.819946	0.706909	1	0	0	no	null	null	no dnr	8	117	15.298828	110	32	37.69531	null	4.299805	1	0.899902	138	null	179	8	2,920	null	null	null	2.275391
8,647	76.82098	1	female	0	10	268	COPD	COPD/CHF/Cirrhosis	6	16	null	0	6,023	4,087.3184	4,534.57812	5.5	white	22.597656	47	0.762939	0.623901	1	0	0	no	0.85	0.75	no dnr	10	55	13.798828	120	6	35.39844	null	2.399902	2.599609	3.099609	140	null	353	132	400	2	0	no(M2 and SIP pres)	0
8,648	84.64294	1	female	0	6	15	Coma	Coma	3	18	null	61	7,579	5,323.4609	6,668.03906	12	white	20.199219	9	0.314941	0.242981	1	1	0	no	0.5	0.5	dnr before sadm	-1	59	7.399414	140	40	39.09375	197.125	2.299805	1.199951	1.099854	140	7.459961	124	26	2,275	null	3	<2 mo. follow-up	3
8,649	42.25299	1	female	1	8	8	MOSF w/Malig	ARF/MOSF	1	null	null	0	36,798	23,911.3906	22,265.8281	33	white	33.695313	43	0.382996	0.263977	15	0	0	yes	0.2	0.1	dnr after sadm	8	80	18.699219	69	16	37.89844	null	3.099609	0.399963	2.299805	135	null	85	38	null	null	null	<2 mo. follow-up	2.008301
8,650	58.48898	0	male	0	29	876	ARF/MOSF w/Sepsis	ARF/MOSF	1	null	null	44	66,086	43,458.0938	45,911.5312	17.25	white	22.398438	51	0.664917	0.567993	9	0	0	no	0.7	0.7	no dnr	29	123	19.398438	110	28	36.19531	261.875	4.399414	0.699951	0.899902	137	7.40918	208	17	2,950	null	0	no(M2 and SIP pres)	0
8,651	75.66095	1	male	0	6	82	Lung Cancer	Cancer	2	10	null	0	6,004	3,841.6426	3,366.2793	10	white	16.5	20	0.691895	0.40094	1	0	0	metastatic	1	1	dnr after sadm	1	57	15.699219	70	22	37	null	2.099609	0.599976	6.5	132	null	120	39	0	0	1	null	1
8,652	85.74396	1	male	1	10	10	COPD	COPD/CHF/Cirrhosis	4	null	under $11k	37	7,922	5,375.1914	5,476.12891	13.5	white	19.898438	22	0.605957	0.416992	1	0	1	no	0.75	0.6	dnr after sadm	1	69	19.097656	68	8	36.39844	213.3125	3.199707	0.5	8.798828	138	7.389648	103	55	0	null	1	<2 mo. follow-up	1
8,653	71.86896	1	male	0	11	87	COPD	COPD/CHF/Cirrhosis	3	14	$11-$25k	0	87,179	59,329.0938	52,506.4688	17.5	white	21	24	0.747925	0.602905	35	0	0	no	0.5	0.4	dnr after sadm	10	77	1.899902	110	20	36.09375	246.65625	null	null	1.399902	136	7.389648	98	60	2,130	0	4	no(M2 and SIP pres)	4
8,654	75.07996	1	male	0	6	60	Lung Cancer	Cancer	1	6	$11-$25k	0	3,316	2,170.2188	2,201.96875	8	white	18.398438	9	0.652954	0.347961	1	0	0	metastatic	1	1	no dnr	6	65	11.199219	62	32	35.79688	155.53125	null	null	1.099854	137	7.439453	164	22	1,105	0	1	null	1
8,655	74.81696	1	female	0	4	292	Lung Cancer	Cancer	2	12	$11-$25k	0	2,259	1,534.4443	1,526.93945	8	white	15.5	29	0.714966	0.435974	1	0	0	metastatic	1	1	no dnr	4	107	7.199219	130	24	36.09375	95.23438	3.799805	1.5	1	133	7.40918	112	15	1,765	0	1	no(M2 and SIP pres)	1
8,656	65.75494	1	male	0	15	112	Colon Cancer	Cancer	3	11	$11-$25k	0	10,259	6,809.7266	7,863.25781	12.666664	white	32.59375	29	0.485962	0.166992	1	1	0	metastatic	0.1	0.01	dnr after sadm	2	99	8.699219	96	20	36.59375	null	3.799805	0.199982	0.699951	127	null	96	10	null	2	3	adl>=4 (>=5 if sur)	3
8,657	68.36096	1	female	0	7	81	Lung Cancer	Cancer	2	12	$11-$25k	0	7,018	4,296.5391	3,172.9082	4	white	11.298828	19	0.79895	0.573975	1	0	0	metastatic	0.7	0.3	dnr after sadm	6	108	14.798828	130	44	35.39844	null	null	null	1.099854	155	null	229	68	1,450	null	null	null	1.981689
8,658	66.94299	1	male	0	6	15	Coma	Coma	1	null	null	100	18,074	12,242.7344	14,080.75	33	white	30	36	0.066986	0.036995	1	1	0	no	0	0	dnr after sadm	6	74	5.399414	66	32	36.29688	390.4375	null	null	1.599854	139	7.459961	1.599854	27	1,100	null	null	<2 mo. follow-up	2.502441
8,659	76.81	0	male	0	9	868	CHF	COPD/CHF/Cirrhosis	5	14	$11-$25k	0	8,619	6,012.4805	5,320.12891	13	white	24.597656	46	0.754883	0.612915	1	1	0	no	0.8	0.6	no dnr	9	75	14.5	142	24	37.89844	132	3	0.5	0.799927	138	7.289062	155	20	1,620	1	2	no(M2 and SIP pres)	2
8,660	66.35498	0	male	0	63	866	ARF/MOSF w/Sepsis	ARF/MOSF	2	13	under $11k	0	116,735	73,369.3125	78,425.4375	38.5	white	22.597656	30	0.821899	0.761963	1	0	0	no	0.9	0.9	no dnr	63	61	5.599609	107	16	35.69531	366.625	3.299805	0.599976	1.199951	134	7.439453	255	17	5,300	null	5	adl>=4 (>=5 if sur)	5
8,661	79.16199	1	male	0	11	343	CHF	COPD/CHF/Cirrhosis	5	14	null	0	8,505	5,740.9141	4,858.60938	16	hispanic	18.796875	18	0.789917	0.66394	1	0	0	yes	0.6	0.5	dnr after sadm	1	59	6.199219	74	44	35.69531	null	null	0.799927	1.299805	141	null	105	25	null	4	3	no(M2 and SIP pres)	3
8,662	56.92499	0	female	0	31	865	COPD	COPD/CHF/Cirrhosis	4	12	null	0	65,550	43,867.9062	48,563.9062	23.5	white	12.599609	22	0.940918	0.899902	1	0	0	no	0.7	0.5	no dnr	31	75	16.398438	49	24	36.39844	202.03125	null	1.199951	1.699951	140	7.209961	280	39	600	0	0	no(M2 and SIP pres)	0
8,663	59.77298	0	male	0	7	864	ARF/MOSF w/Sepsis	ARF/MOSF	0	12	under $11k	0	18,898	13,060.3906	14,050.4531	4.5	white	16.699219	20	0.868896	0.822998	9	0	0	no	0.99	0.95	no dnr	7	76	11.099609	65	24	36.09375	295.1875	null	0.799927	1.899902	140	7.429688	125	49	null	null	0	no(M2 and SIP pres)	0
8,664	81.20496	1	female	1	5	5	Coma	Coma	0	12	$11-$25k	100	6,553	5,017.4922	4,987.24609	23	white	18.699219	18	0.195984	0.136993	1	0	0	no	null	null	dnr after sadm	3	54	7.099609	70	20	37.79688	null	2.5	0.299988	0.799927	136	null	132	3	1,325	null	null	<2 mo. follow-up	2.507813
8,665	40.55298	1	male	1	4	4	Coma	Coma	0	0	under $11k	94	5,672	3,994.7324	4,038.21875	17	white	39.796875	41	0.07399	0.040993	1	0	0	no	null	null	dnr after sadm	1	68	10.398438	64	40	36.09375	268	2.5	3.899902	0.799927	137	7.40918	168	25	4,550	null	null	<2 mo. follow-up	2.371094
8,666	37.94098	1	male	1	4	4	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	under $11k	0	15,509	11,319.9766	10,618.1797	28	white	40.898438	77	0.541992	0.427979	5	1	0	no	0.7	0.6	no dnr	4	81	11.699219	77	20	36.39844	null	2.599609	18	1	140	null	119	10	775	null	2	<2 mo. follow-up	2
8,667	73.03796	0	male	0	7	860	CHF	COPD/CHF/Cirrhosis	4	8	under $11k	0	8,538	5,824.7461	5,886.95703	10	white	20.296875	29	0.833984	0.727905	1	1	0	no	0.75	0.6	no dnr	7	76	7	61	24	36.39844	null	2.599609	0.5	1.099854	133	null	98	43	2,100	0	null	null	0.494751
8,668	52.40799	1	female	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	1	9	null	100	15,597	9,914.5703	10,317.7266	43	white	33.59375	87	0.21698	0.119995	1	0	0	no	0.01	0	no dnr	3	41	0.099991	196	36	38.19531	351	3	0.699951	2.199707	145	7.519531	256	91	1,375	null	null	<2 mo. follow-up	3.301758
8,669	47.04398	1	male	1	3	3	ARF/MOSF w/Sepsis	ARF/MOSF	3	12	$11-$25k	100	22,789	17,392.75	13,695.9766	28	white	47.59375	106	0.003	0	13	1	0	no	0.3	0.2	no dnr	3	133	15.798828	122	40	36.69531	157.5	2.599609	1.599854	1.699951	146	7.429688	173	55	null	null	null	<2 mo. follow-up	3.734375
8,670	69.77399	1	male	1	7	7	MOSF w/Malig	ARF/MOSF	4	12	$11-$25k	0	23,180	15,646.0391	18,409.2031	20	white	22.597656	58	0.606934	0.500977	4	0	0	metastatic	0	0	dnr after sadm	6	73	22.398438	104	40	39	142.5	null	null	1.299805	145	7.419922	151	53	1,900	null	0	<2 mo. follow-up	0
8,671	71.64099	1	male	0	54	269	MOSF w/Malig	ARF/MOSF	3	14	$25-$50k	0	75,094	50,020.4688	56,390.4062	21.5	white	30.699219	51	0.42395	0.303955	11	0	0	yes	null	null	no dnr	54	56	36.5	70	40	36.59375	254.28125	2.399902	1.199951	1.199951	138	7.419922	217	76	760	null	0	no(M2 and SIP pres)	0
8,672	75.78894	1	male	0	5	217	Lung Cancer	Cancer	3	8	$11-$25k	0	2,268	1,554.6572	1,590.97949	14	white	10.298828	13	0.800903	0.577881	1	0	0	metastatic	0.6	0.4	dnr after sadm	2	109	9.5	80	30	38.79688	101.42188	null	null	1.699951	152	7.479492	136	51	3,515	0	0	no(M2 and SIP pres)	0
8,673	83.54596	0	male	0	5	853	COPD	COPD/CHF/Cirrhosis	2	7	null	9	3,826	2,541.1699	3,267.94922	13	white	22.699219	34	0.67688	0.506958	1	0	0	no	0.5	0.45	dnr after sadm	3	69	21.898438	122	24	36.79688	null	3.299805	1	1	138	null	177	20	1,245	null	2	no(M2 and SIP pres)	2
8,674	65.29999	1	male	0	5	452	Colon Cancer	Cancer	1	10	$11-$25k	0	2,361	1,575.5684	1,510.62988	10	white	17.898438	17	0.803955	0.582886	1	0	0	metastatic	null	null	dnr after sadm	1	79	61.195313	87	24	37	null	2.699707	4.199219	1.599854	135	null	185	14	null	0	null	no(M2 and SIP pres)	0.494751
8,675	67.625	1	male	0	3	70	Colon Cancer	Cancer	1	8	under $11k	0	3,589	2,204.9473	2,238.87891	null	white	15.798828	7	0.827881	0.626953	1	0	0	metastatic	0.4	0.05	no dnr	3	76	10.599609	60	32	35.59375	142.84375	null	null	1	141	7.399414	247	21	4,750	null	null	null	1.69458
8,676	70.76794	1	male	0	8	9	Lung Cancer	Cancer	1	11	under $11k	0	9,416	5,896.3711	4,755.94922	15.5	white	15.798828	11	0.717896	0.439941	1	0	0	metastatic	0.1	0	dnr after sadm	3	106	17.097656	101	24	36.79688	147.59375	3.299805	0.299988	0.899902	143	7.349609	146	19	null	null	1	<2 mo. follow-up	1
8,677	21.99899	1	male	0	46	247	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$25-$50k	9	109,718	77,263.5	83,218.8125	40.75	white	37.5	37	0.696899	0.605957	3	0	0	no	null	null	no dnr	46	113	13.798828	105	32	38.39844	290	null	0.599976	1	138	7.40918	98	20	960	null	6	adl>=4 (>=5 if sur)	6
8,678	83.82495	1	female	1	31	31	ARF/MOSF w/Sepsis	ARF/MOSF	0	null	null	0	93,539	63,046.8438	66,939.0625	41.25	white	40.09375	84	0.207977	0.113998	15	0	0	no	0.8	0.8	no dnr	31	113	7.199219	77	12	36	null	4	2.099609	1	132	null	196	4	3,995	null	null	<2 mo. follow-up	2.48291
8,679	56.75598	1	male	0	5	483	Lung Cancer	Cancer	1	null	null	0	4,327	2,830.0215	2,285.85938	10	white	11.099609	13	0.820923	0.612915	1	0	0	metastatic	0.95	0.8	no dnr	5	59	9.898438	130	10	39.09375	93.32812	2.199707	1.099854	4.899414	138	7.179688	122	70	1,220	null	null	null	1.834473
8,680	83.15094	1	male	0	7	304	CHF	COPD/CHF/Cirrhosis	6	8	null	0	5,243	3,663.084	3,145.23828	6	white	26.5	55	0.619995	0.434998	1	1	0	yes	0.8	0.5	no dnr	7	78	13.699219	100	26	36.39844	207.5	2.399902	0.799927	2.099609	137	7.40918	141	50	3,675	4	2	SIP>=30	2
8,681	76.19995	1	male	0	15	16	MOSF w/Malig	ARF/MOSF	4	12	$11-$25k	26	90,858	56,111.8438	64,436.3125	18.666656	white	31.597656	66	0.222992	0.125	40	1	0	yes	0.5	0.5	dnr before sadm	-39	74	null	110	10	38.79688	171.40625	null	null	0.899902	141	7.469727	161	28	2,375	null	1	<2 mo. follow-up	1
8,682	66.97894	1	female	0	9	220	COPD	COPD/CHF/Cirrhosis	6	13	$11-$25k	0	11,621	7,526.9648	8,539.84375	16	white	20.796875	34	0.80896	0.690918	1	1	0	yes	0.9	0.8	dnr after sadm	1	106	8.599609	110	24	36.39844	261.875	null	0.5	2.799805	137	7.379883	119	60	null	0	0	no(M2 and SIP pres)	0
8,683	68.04395	1	male	0	20	411	Coma	Coma	3	8	$11-$25k	55	32,601	21,729.9375	24,082.9062	32.666657	white	25.796875	42	0.352966	0.279968	1	0	0	no	null	null	no dnr	20	123	4.899414	76	20	36.19531	null	3.099609	0.899902	10	139	null	98	62	170	null	0	no(M2 and SIP pres)	0
8,684	92.33398	0	male	0	8	838	CHF	COPD/CHF/Cirrhosis	2	12	null	0	3,869	2,705.2637	2,730.59961	2.5	white	23.398438	32	0.698975	0.534912	1	0	0	no	0.8	0.7	no dnr	8	135	0.699951	112	8	39.39844	103.32812	null	null	5.099609	134	7.299805	90	83	133	2	1	no(M2 and SIP pres)	1
8,685	77.61298	0	male	0	5	836	COPD	COPD/CHF/Cirrhosis	3	13	$11-$25k	0	3,524	2,386.709	2,585.11914	8	white	13.898438	9	0.870972	0.786987	1	1	0	no	null	null	no dnr	5	71	17.199219	162	30	39.39844	145	1.799805	0.299988	0.599976	126	7.399414	182	12	2,175	0	1	null	1
8,686	86.73499	1	male	0	11	126	MOSF w/Malig	ARF/MOSF	4	9	under $11k	0	11,041	7,323.082	7,199.44922	16	white	21.699219	27	0.652954	0.553955	1	0	0	metastatic	0.65	0.1	dnr before sadm	-1	112	11.398438	76	20	36.19531	392	null	0.599976	1.699951	135	7.469727	318	26	2,000	5	5	no(M2 and SIP pres)	5
8,687	50.20697	1	male	0	4	95	CHF	COPD/CHF/Cirrhosis	3	12	$25-$50k	0	5,789	3,933.3066	4,027.1582	18	white	18.097656	14	0.911987	0.851929	1	0	0	no	0.8	0.6	no dnr	4	93	4.799805	73	16	37.09375	null	3.799805	0.599976	1	137	null	116	7	1,300	0	0	no(M2 and SIP pres)	0
8,688	50.69098	1	male	0	4	345	Lung Cancer	Cancer	1	16	>$50k	0	7,055	4,063.3086	2,812.0293	11	white	9.699219	9	0.846924	0.661987	1	0	0	metastatic	0.7	0.5	no dnr	4	73	7.5	63	20	35	476.1875	null	null	1.199951	132	7.549805	130	32	975	0	0	no(M2 and SIP pres)	0
8,689	40.09299	1	male	0	22	265	CHF	COPD/CHF/Cirrhosis	3	18	$25-$50k	0	96,734	68,584.5	49,297.25	7	white	24	43	0.887939	0.812988	1	0	0	no	0.9	0.7	no dnr	22	110	29.5	86	28	36.19531	240	null	0.299988	1.099854	131	7.419922	346	29	3,325	null	0	no(M2 and SIP pres)	0
8,690	60.35599	0	female	0	10	827	COPD	COPD/CHF/Cirrhosis	2	12	$25-$50k	0	7,059	4,664.6719	4,985.94922	9.5	white	23.199219	24	0.850952	0.754883	1	1	0	no	1	1	no dnr	10	60	17	155	24	35.19531	414.25	3.299805	1	1.799805	137	7.479492	75	24	null	0	0	null	0
8,691	59.60797	0	male	0	7	827	COPD	COPD/CHF/Cirrhosis	5	11	$11-$25k	0	6,488	4,236.8203	4,441.97656	8.5	white	18.296875	22	0.899902	0.832886	1	1	0	no	null	null	dnr after sadm	1	81	7.699219	83	26	37.09375	247.59375	null	null	2	138	7.479492	101	24	2,450	0	0	no(M2 and SIP pres)	0
8,692	85.06494	1	female	0	13	74	COPD	COPD/CHF/Cirrhosis	2	12	under $11k	9	9,352	6,178.2148	5,490.21875	11	white	17.296875	30	0.765991	0.62793	1	0	0	no	0.95	0.8	dnr after sadm	1	74	5.899414	77	20	36.59375	204.75	null	1	1	134	7.469727	118	10	3,425	1	6	adl>=4 (>=5 if sur)	6
8,693	68.84296	1	male	0	12	126	Lung Cancer	Cancer	3	12	$11-$25k	0	9,346	6,076.0195	5,872.84766	5	white	31.199219	15	0.320984	0.059998	1	0	0	metastatic	1	0.55	dnr after sadm	1	60	26.097656	108	10	38.39844	125	2.299805	15.199219	2.199707	135	7.359375	208	40	3,690	3	2	adl>=4 (>=5 if sur)	2
8,694	68.45197	0	female	0	4	825	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	$11-$25k	0	4,204	2,914.7578	3,383.51953	9	white	20.597656	22	0.839966	0.785889	1	0	0	no	0.9	0.8	no dnr	4	58	null	66	8	38.79688	184.4375	null	null	null	140	7.469727	null	null	1,842	0	0	no(M2 and SIP pres)	0
8,695	24.18599	0	female	0	9	822	Coma	Coma	2	12	under $11k	26	10,604	7,159.0547	7,792.70703	15.5	white	25	25	0.830933	0.797974	1	0	0	no	0.9	0.9	no dnr	9	65	19.699219	118	60	38.59375	73.75	2.5	1.899902	1	143	7.459961	159	29	2,265	0	0	no(M2 and SIP pres)	0
8,696	69.84796	1	male	0	20	24	Coma	Coma	2	10	$11-$25k	89	58,550	42,939.125	39,554.25	35.666657	white	24.898438	47	0.13797	0.088989	4	0	0	no	0.5	0.4	dnr after sadm	10	67	null	49	20	35.69531	null	null	null	1.299805	140	null	105	29	2,705	null	2	<2 mo. follow-up	2
8,697	58.185	0	female	0	21	820	Coma	Coma	0	12	>$50k	44	28,158	20,724.0938	20,050.7969	21	white	20.5	21	0.644897	0.584961	1	0	0	no	0.8	0.7	no dnr	21	77	null	96	22	37.59375	null	null	null	null	140	null	null	null	null	null	0	no(M2 and SIP pres)	0
8,698	70.35999	1	female	0	6	51	Colon Cancer	Cancer	1	12	null	9	4,961	3,193.9883	3,224.61914	16	white	36.195313	53	0.313965	0.056999	1	0	0	metastatic	0.3	0.1	dnr after sadm	1	65	22	98	12	39.79688	165	10.898438	8.798828	1.5	133	7.439453	164	55	2,325	0	null	<2 mo. follow-up	0.494751
8,699	57.547	1	male	0	5	8	ARF/MOSF w/Sepsis	ARF/MOSF	1	12	>$50k	89	18,402	12,561.375	12,977.5156	28	white	20.699219	26	0.546997	0.43396	4	0	0	no	0.1	0.1	dnr after sadm	3	121	7.399414	83	20	35.79688	328.5625	3.199707	0.299988	5.699219	137	7.439453	195	57	3,425	null	0	<2 mo. follow-up	0
8,700	62.22897	0	male	0	11	820	ARF/MOSF w/Sepsis	ARF/MOSF	4	12	$11-$25k	0	11,740	8,060.9922	9,392.5625	14	white	19.097656	12	0.872925	0.828979	1	1	0	no	null	null	no dnr	11	101	18.398438	66	24	35.59375	null	null	null	1.199951	137	null	191	16	4,900	null	0	adl>=4 (>=5 if sur)	0